C
omorbidities are medical conditions that, like hypertension, depression, and diabetes mellitus, can affect the extent to which a musculoskeletal condition impacts an individual, as well as an individual's ability to recover during rehabilitation. 16, 51, 53, 56, 63, 67 For example, the presence of comorbidity has been associated with increased number of episodes and longer duration of work-related disability in individuals with low back pain. 49, 53 Additionally, depression is one comorbidity that has been shown to influence outcomes in individuals following hip fracture. 21, 23 The presence of comorbidities may warrant additional diagnostic testing or modification to a rehabilitative treatment regime. 1, 6, 26, 48 Comorbidities such as osteoporosis, cancer, and neurological disease preclude the use of specific physical therapy intervention such as manual therapy.
14 Therefore, physical T T STUDY DESIGN: Secondary analysis, crosssectional study.
T T OBJECTIVES:
To (1) compare differences in individual comorbidity rates among patients with cervical, lumbar, and extremity pain complaints and (2) compare rates based on total number and severity in these same patient groups.
T T BACKGROUND:
Comorbidities can impact recovery, prognosis, and potentially hinder participation in rehabilitation. Few studies have compared comorbidity rates among patients with different anatomical region of pain, to determine whether specific screening is warranted in physical therapy settings.
T T METHODS: Included in the analyses were 2375
patients who reported complete demographic, clinical, and comorbidity information using Patient Inquiry software. Comorbidity data were collected from the Functional Comorbidity Index (18 items) and 6 additional comorbidities, to assess the presence of medical disease across multiple body systems. Comorbidities were further classified as "nonsevere" or "severe," based on inclusion in the Charlson Comorbidity Index. Chi-square analyses investigated differences in the rates of total number and severe comorbidities. Odds ratios (OR) and 95% confidence intervals (CIs) were calculated on rates with statistically significant differences (P<.001), using the lumbar spine as the reference group. 51 , 0.80) were associated with cervical conditions. There were no differences among the 3 anatomical regions for total number or severe comorbidities.
T T CONCLUSION:
Focused screening for degenerative disc disease, obesity, and headache may be warranted. However, the same strategy was not supported for total number or severe comorbidities, at least when considering comparative rates from this cohort. Physical therapists should consider the potential influence of total number and severe comorbidities equally for all anatomical regions of musculoskeletal pain. therapists should acknowledge the presence of comorbidities and understand their potential influence on musculoskeletal pain management. The majority of studies reporting comorbidity prevalence rates have examined them among patients with specific musculoskeletal conditions, namely arthritis and low back pain. 24, 28, 44, 51, 53, 55, 58, 63 Fewer studies have examined the rates of comorbidities in patients receiving outpatient physical therapy. 7, 9, 10, 16 Boissonnault 7 and Boissonnault and Koopmeiners 10 conducted multicenter trials examining comorbidities reported by patients treated in physical therapy. Headache, hypertension, arthritis, and depression were among the most frequently observed comorbidities; however, rates were not compared between patients with pain complaints in different anatomical regions. 7, 10 Direct comparison of comorbidity rates between patients with different musculoskeletal conditions is not widely reported. 16, 52 Determining whether comorbidity rates differ among common musculoskeletal conditions is clinically relevant to physical therapy practice, because of the potential association of a specific comorbidity with an anatomical region. For example, cancer is a commonly mentioned disease that masks as a lumbar spine condition. 6, 17, 18, 26 A clinician's suspicion of cancer and its potential influence on the course of care may be heightened when treating a patient aged greater than 50 years with a lumbar spine condition compared to treating a patient with a musculoskeletal problem of the extremity. Similarly, screening for incontinence is recommended almost exclusively for patients with lumbar conditions and not recognized as a common issue among patients with cervical or extremity conditions. 19, 20 Differences in comorbidity rates may potentially guide clinicians on the appropriateness of focused or anatomical region-specific screening for specific musculoskeletal conditions.
T T LEVEL OF EVIDENCE:
A second concern with epidemiological studies is that comorbidities are often not classified by severity but grouped together and considered the same. Few studies have examined comorbidity rates in this manner. 45, 50, 59 The presence of severe comorbidities may negatively impact the prognosis of a patient compared to the presence of nonsevere comorbidities. Picirillo et al 50 used a hospital-based registry of patients with cancer to conduct an observational study of the relationship of comorbidity severity (eg, mild, moderate, or severe) to survival time. The authors found that the hazard ratios (indicating a higher number of deaths) associated with severe comorbidities were consistently higher than for nonsevere comorbidities. 50 These results support the need to examine rates of different types of comorbidity. To the best of our knowledge, data evaluating comorbidities based on severity for patients seen in outpatient orthopaedic physical therapy clinics has not been reported in the literature.
Therefore, the primary goal of this study was to examine the rates of medical comorbidities in a sample of patients receiving outpatient orthopaedic physical therapy. Our specific aims were to (1) compare individual comorbidity rates across patients with pain complaints in the cervical, lumbar, and extremity region, and (2) investigate differences in comorbidity rates, based on total number and severity between anatomical region of symptoms. The results of this study may potentially highlight whether focused screening is warranted in physical therapy and if the total number and severity of comorbidities demonstrate a differential pattern based on anatomical region of symptoms. We hypothesized that there would be equal rates for total number and severity of comorbidities, based on anatomical region.
METHODS

Study Design
T his study is a cross-sectional, secondary analysis of a larger prospective, observational study. 22 Only intake information provided by participants completing comorbidity questionnaires was included in this study. Data were collected prospectively, from March 2005 to July 2009, from outpatient orthopaedic physical therapy clinics participating with Focus On Therapeutic Outcomes, Inc (FOTO, Inc, Knoxville, TN). 16, 61, 62 The software used for clinical data collection (Patient Inquiry; FOTO, Inc) has been well described in other publications. 15, 65, 66 The collection of patient data was approved by FOTO's Institutional Review Board for the Protection of Human Subjects and the use of the deidentified data for this analysis was approved by the Institutional Review Board for the Protection of Human Subjects at the University of Florida.
Participants
A convenience sample of patients from 37 outpatient orthopaedic physical therapy clinics, across 22 states in the United States, was included in this study. The patient sample for this analysis came from a larger group of similar patients (n = 8939) seen in a variety of outpatient physical therapy clinics specializing in industrial rehabilitation, neurology, orthopaedics, and pain. Only patients managed in orthopaedic physical therapy clinics (n = 7031) were initially considered for this analysis. Additionally, patient data were excluded if patients did not respond to comorbidity questions, which was primarily the result of clinics that did not collect comorbidity data. Data from 2375 patients were included in this analysis. Comparison of demographic variables between the larger sample (n = 8939) and the sample of patients included in this study (n = 2375) revealed no difference for sex or intake pain intensity (P>.05). A statistical difference was observed for age and intake functional score (P<.01), indicating that patients in this analysis were younger and reported higher functional scores in comparison to the larger cohort.
All patients were seeking treatment for musculoskeletal pain complaints in 1 of 3 body areas: cervical spine, lumbar spine, or upper or lower extremity. For the purposes of this analysis, as in the primary analysis, we defined these areas as separate anatomical regions. 22 We chose to categorize patients into these 3 anatomical regions, because our primary interest was comparing spinal pain with extremity pain. Our hypothesis was based on these anatomical regions rather than specific locations or diagnoses. In addition, these 3 groupings reflect general areas of pain complaints reported by patients evaluated in outpatient physical therapy.
Demographic and Clinical Factors
Participants provided the following information at intake: age (below 18 Clinical pain intensity was assessed at intake using a numerical rating scale, 43 which is an 11-point scale, with 0 meaning "no pain" and 10 the "worst pain ever." The numerical rating scale has demonstrated good psychometric properties for the assessment of musculoskeletal pain. 13, 47 The patient's functional status was assessed on a 101-point scale, with 0 representing "very low functioning" and 100 "very high functioning." Functional status has been shown in prior studies to be a valid and reliable tool with computer adaptive testing methods. [29] [30] [31] [32] [33] [34] [35] [36] 
Comorbidity Measures
Eighteen of the 24 comorbidities were assessed using the Functional Comorbidity Index (FCI) developed by Groll et al. 27 Developed from 2 comprehensive databases for osteoporosis risk and spinerelated ailments, the FCI is an 18-item measure on which individuals indicate the presence or absence of a specific comorbidity. The FCI can be scored on a scale of 0 to 18, with 18 indicating the highest number of comorbidities, 27 which include angina, anxiety, arthritis, asthma, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), depression, degenerative disc disease (DDD), diabetes mellitus, gastrointestinal disease, hearing impairment, myocardial infarction (MI), neurological disease, obesity, osteoporosis, peripheral vascular disease (PVD), stroke, and visual impairment. The remainder of medical comorbidities queried included allergy, cancer, headache, hypertension, incontinence, and kidney disease. These comorbidities were included as they were also reported in prior prevalence studies. 7, 10 Total comorbidities for an individual were considered as the sum of all comorbidities reported. Nine of the above comorbidities were classified as severe, based on those listed in the Charlson Comorbidity Index. 11 This index contains comorbidities associated with higher incidence of mortality, which include cancer, COPD, CHF, diabetes mellitus, kidney disease, MI, neurological disease, PVD, and stroke. All other medical comorbidities were considered nonsevere by default.
Statistical Analysis
Data were analyzed with SPSS for Windows, Version 17.0 (SPSS Inc, Chicago, IL). Chi-square analyses were used to investigate differences in individual comorbidity rates between the 3 musculoskeletal conditions. We used a similar analytical strategy for investigating differences in rates based on (1) total number of comorbidities, (2) total number of severe comorbidities, and (3) those with at least 1 severe comorbidity. Odds ratios (ORs) and 95% confidence intervals (CIs) were generated for individual comorbidity rates observed to be statistically significant and for the combined comorbidity rates. For ORs, we used the lumbar spine as the reference group. Due to the large sample size and multiple No significant differences were observed among the 3 anatomical regions for total number of comorbidities (χ 2 = 6.6, P = .359) or total number of severe comorbidities (χ 2 = 13.6, P = .034) (FIG-URES 1 and 2) . No significant difference was observed among anatomical regions for rate of patients with at least 1 severe comorbidity (χ 2 = 7.4, P = .0250). Observation of ORs (eg, strength of association) revealed small differences among anatomical regions when the lumbar spine was the reference (TABLE 3) . For example, the largest difference noted was in the reporting of severe comorbidities, in which individuals with cervical or extremity conditions were half as likely to present with 3 or more severe comorbidities as those with lumbar conditions. DISCUSSION W e examined comorbidity rates among patients seen in various outpatient physical therapy clinics across the United States. We compared these rates across 3 different anatomical regions. Three nonsevere comorbidities demonstrated differences in rates between patients, with symptoms in the lumbar spine, cervical spine, and extremity regions. No difference was observed in the total number or severe comorbidity rates. These data suggest that outpatient physical therapists should not target screening for comorbidities to specific anatomical regions, such as the lumbar spine, due to concerns related to cancer, for example. 6, 17, 18, 26 Instead, physical therapists should screen for comorbidities, including those considered severe, regardless of the patient's anatomical region of symptoms.
Prior studies have reported comorbidity prevalence rates among patients receiving physical therapy and have highlighted several common comorbidities in this population. 7, 10, 16, 52 The most commonly observed comorbidities across all studies include arthritis, DDD, depression, and hypertension. Headache and obesity were also observed as prevalent comorbidities in the studies by Boissonnault 7 and Resnik et al, 52 respectively. In the current study, 3 of these 5 nonsevere comorbidities (DDD, obesity, and headache) were found to have differing rates among patients with different musculoskeletal conditions. Not surprisingly, headache was more prevalent in patients with cervical conditions. Associations between neck pain and headache have been reported, and the presence of headache has been implicated as an important factor in outcome in patients with both nonspecific and specific neck pain pathology such as whiplash-associated disorder. 2, [40] [41] [42] This association has led to a neck pain and headache treatment-based subgroup in recent clinical guidelines for the treatment of neck pain. 12 Thus, screening for headache in patients with cervical conditions potentially has implications for both prognosis and treatment.
The higher rate of DDD in patients with cervical and lumbar conditions is intuitive, as these patients are likely informed of degenerative changes on radiographic or other advanced imaging. Degenerative changes observed on spinal imaging are not uncommon, even in those who do not complain of spinal region pain or other symptoms. 4, 5, 39, 64 The lower rate of obesity observed in patients with cervical conditions is less clear. This "protective" association is consistent with the results from Deutscher 16 and Resnik. 16, 52 One explanation for the relatively higher rate of obesity in lumbar and lower extremity conditions may be the potential role of obesity in these conditions, as higher body mass index has been associated with prevalence of low back pain and knee osteoarthritis. 3, 38, 46 Clinically, this finding may be important in treatment considerations, as weight reduction programs may be an appropriate intervention in these populations.
Our results suggest that focused screening for headache, DDD, and obesity may be warranted; however, a similar strategy does not seem to be supported for the severe comorbidities, at least when considering comorbidity rates from this cohort. These findings have relevance for physical therapist education and practice. Physical therapists are potentially first-contact practitioners, and curricular components devoted to differential diagnosis and medical screening for all anatomical regions would enhance understanding of comorbid medical conditions. In clinical practice, attention to severe medical comorbidities is paramount. Of considerable note is the rate of patients with cancer. One of the strongest diagnostic indicators for cancer as the cause of low back pain is a prior his- [ research report ] tory of cancer. 17, 18, 37 While this highlights the importance of cancer screening for low back pain, our results suggest equal importance in cancer screening for the anatomical regions of musculoskeletal pain included in this analysis.
A novel aspect of this study was the distinction between severe and nonsevere comorbidities. This strategy is not commonly used in comorbidity studies but may have relevance to clinical practice.
Medical screening is an integral part of the physical therapy evaluation. 1, 6, 26, 57 There are several reasons to recommend screening in the outpatient setting, including direct access by physical therapists, referral by other providers without examination or attention to red flags, and development or progression of symptoms associated with disease over time. 25, 54 Important historical information such as presence of severe medical comorbidity should be routinely obtained, and our data suggest equal importance of screening for total number and severe comorbidities among patients with spine and extremity conditions. This screening may assist in decision making related to therapeutic interventions or referral to a physician for further medical workup or diagnostic imaging.
Limitations
One limitation of the current study is that we included a sample of convenience. The included sample of patients came from a larger cohort with observed differences in age and functional status, which suggests a younger, healthier subset of patients. 22 This difference may limit application to patients presenting to outpatient orthopaedic physical therapy. Furthermore, we limited our analysis to a sample of patients who completed comorbidity questionnaires. This might have impacted the reported rates (rates might have been overestimated), thus the estimates reported in this paper should not be mistaken for actual prevalence rates. Specifically, these rates are best interpreted relative to the other anatomical regions included in this paper. Another limitation is that we did not analyze comorbidity rates across specific clinical diagnoses. As mentioned previously, our aim was to compare comorbidity rates between individuals with spinal pain and extremity pain. We did not have specific hypotheses for differences in rates among specific diagnoses. Thus, our findings may be valid only to the specific grouping of anatomical regions used in this study. Similarly, the data were coded such that we could not distinguish whether individual patients reported multiple regions of pain. Patients with multiple pain sites may have different health history profiles.
The 24 comorbidities assessed in this study do not represent an exhaustive list of comorbidities and were limited to those included in prior studies and validated comorbidity indexes. 7, [9] [10] [11] 16, 27, 52 While we present rates of severe comorbidities, it should be noted that severity was based on an index of higher mortality. It may be relevant to assess differences in comorbidity rate based on another measure of severity. Additionally, due to the large sample size, it was not possible to confirm the patients' self-report of comorbidities with medical records. However, the use of self-administered questionnaires has been shown to be accurate for attaining clinical information. 8 We utilized a conservative significance value of P<.001 due to our large sample size; however, we noted small differences in the strength of association between anatomical regions and the various comorbidity groupings that might have been more related to sample size than clinical relevance. Finally, our analyses of comorbidity status were limited to the reporting of rates and associations with intake clinical measures. We did not perform analyses on the impact of comorbidity status on outcome following rehabilitation, as this was beyond the scope of the current analysis. Future studies should consider the impact of total number and severity of comorbidities on clinical outcomes.
CONCLUSION
T he rates of 3 nonsevere comorbidities (headache, DDD, and obesity) differed, based on anatomical region of musculoskeletal complaints. However, we did not observe a difference in the rates of total number or severity of comorbidities based on anatomical region. During clinical examination, physical therapists should consider the number and presence of severe comorbidities in patients, regardless of anatomical region. T
KEY POINTS FINDINGS:
The rates of 3 nonsevere comorbidities (DDD, headache, and obesity) differed in patients with pain complaints in the cervical, extremity, and lumbar regions. No difference was observed in the rates of total number or severe comorbidities based on anatomical region of pain.
IMPLICATION:
Anatomical-specific screening appears to be warranted for degenerative disc disease, headache, and obesity. Screening for total comorbidities, including those considered severe, should be given equal consideration for anatomical region included in this study. CAUTION : We included a convenience sample that included patients younger and healthier than that of the larger cohort. The findings are limited to how the measurement of anatomical region of pain complaint and 24 comorbidities were implemented in this study.
